Kinnate Biopharma Ownership 2024 | Who Owns Kinnate Biopharma Now?
Institutional Ownership
73.45%
Insider Ownership
0.16%
Retail Ownership
26.40%
Institutional Holders
60.00
Kinnate Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -24,721 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -27,778 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -40,500 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,076,789 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -14,185 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -91,961 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -63,090 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -7,427 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -964,881 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -354,121 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -14,254 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -114,846 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -887,740 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -8,009,729 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -68,700 | -100.00% | - | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | - | - | - | -1,820,462 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,933 | -100.00% | - | Jun 30, 2024 |
Kinnate Biopharma's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -24,721 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -27,778 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -40,500 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,076,789 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -14,185 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -91,961 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -63,090 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -7,427 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -964,881 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -354,121 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -14,254 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -114,846 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -887,740 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -8,009,729 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -68,700 | -100.00% | - | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | - | - | - | -1,820,462 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,933 | -100.00% | - | Jun 30, 2024 |
The largest Kinnate Biopharma shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Kinnate Biopharma (KNTE), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -818 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,091 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,933 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -4,102 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -6,262 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -7,427 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,200 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -11,445 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -14,095 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -14,185 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -14,254 | -100.00% | - | Jun 30, 2024 |
| SHAY CAPITAL LLC | - | - | - | -19,411 | -100.00% | - | Jun 30, 2024 |
| BBR PARTNERS, LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,819 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -20,925 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -21,764 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -23,187 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24,721 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Kinnate Biopharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.14K stocks of KNTE, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, LLC | - | - | - | -9,671,643 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -8,009,729 | -100.00% | - | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT V, LLC | - | - | - | -3,525,957 | -100.00% | - | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -1,981,106 | -100.00% | - | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | - | - | - | -1,820,462 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,076,789 | -100.00% | - | Jun 30, 2024 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -1,039,800 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -977,626 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -964,881 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -887,740 | -100.00% | - | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -498,851 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -496,840 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -431,406 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -354,121 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -334,694 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -267,355 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -244,151 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -156,089 | -100.00% | - | Jun 30, 2024 |
| TRIUM CAPITAL LLP | - | - | - | -117,456 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -114,846 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Kinnate Biopharma's biggest institutional seller is FORESITE CAPITAL MANAGEMENT IV, LLC. The company sold -9.67M shares of KNTE, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FORESITE CAPITAL MANAGEMENT IV, LLC | - | - | - | -9,671,643 | -100.00% | - | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | - | - | - | -8,009,729 | -100.00% | - | Jun 30, 2024 |
| FORESITE CAPITAL MANAGEMENT V, LLC | - | - | - | -3,525,957 | -100.00% | - | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -1,981,106 | -100.00% | - | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | - | - | - | -1,820,462 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,076,789 | -100.00% | - | Jun 30, 2024 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -1,039,800 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -977,626 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -964,881 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -887,740 | -100.00% | - | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -498,851 | -100.00% | - | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -496,840 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -431,406 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -354,121 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -334,694 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -267,355 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -244,151 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -156,089 | -100.00% | - | Jun 30, 2024 |
| TRIUM CAPITAL LLP | - | - | - | -117,456 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -114,846 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -104,437 | -100.00% | - | Jun 30, 2024 |
| EQUITEC PROPRIETARY MARKETS, LLC | - | - | - | -103,000 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -91,961 | -100.00% | - | Jun 30, 2024 |
| CSS LLC/IL | - | - | - | -68,700 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -63,090 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -60,038 | -100.00% | - | Jun 30, 2024 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | - | - | - | -51,200 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -48,500 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -40,500 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -27,778 | -100.00% | - | Jun 30, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -24,721 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -23,187 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -21,764 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -20,925 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -20,819 | -100.00% | - | Jun 30, 2024 |
| BBR PARTNERS, LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| SHAY CAPITAL LLC | - | - | - | -19,411 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -14,254 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -14,185 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -14,095 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -11,445 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,200 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -7,427 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -6,262 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -4,102 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,933 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,800 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -1,091 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -818 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -144 | -100.00% | - | Jun 30, 2024 |
Kinnate Biopharma's largest sold out institutional shareholder by shares sold is FORESITE CAPITAL MANAGEMENT IV, LLC, sold -9.67M shares, valued at -, as of undefined.
Kinnate Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BlackRock Health Sciences Trust II | 0.07% | 196,773 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 25,767 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.05% | 4,300 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 79,300 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.03% | 288,156 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.02% | 546 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.02% | 175,853 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 50,697 | 806 | 1.62% | Feb 29, 2024 |
| Federated Hermes Equity Funds | 0.02% | 307,800 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 40,000 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 340,001 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 46,139 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,245 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,184 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 351,780 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,028,887 | -230,466 | -18.30% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.00% | 19,806 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 183,449 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 13,381 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 383 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 80,000 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 47,490 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 32,864 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 28,000 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 180,583 | 11,983 | 7.11% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,973 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,715 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 15,091 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 8,836 | - | - | Dec 31, 2023 |
| BlackRock ETF Trust | 0.00% | 369 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,075 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 863 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 4,349 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 5,361 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 9,080 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 962 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 83,528 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 34,613 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,000 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 46,824 | 39,765 | 563.32% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 14,660 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,534 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,460 | 6,402 | 605.10% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 270 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 254,080 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 695 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 104,631 | - | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 4,487 | - | - | Feb 29, 2024 |
| FIDELITY INVESTMENT TRUST | 0.00% | 8,900 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 175,000 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,570 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 10,755 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,354 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 133 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 639 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 370 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,134 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 80,721 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 153 | - | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 68 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 18 | - | - | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 912 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,600 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,002 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,927 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 4,911 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 24,400 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,174 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 9,473 | 8,257 | 679.03% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,348 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 890 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 8,440 | - | - | Mar 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 17,369 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 152 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 17,384 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,132 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 810 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 64,095 | -1,422 | -2.17% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 1,189 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 794 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,121 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 8,223 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 9,740 | - | - | Mar 28, 2024 |
| PACIFIC SELECT FUND | 0.00% | 5,163 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 1,670 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,835 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 3,800 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 92 | -24 | -20.69% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,558 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,700 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 772 | 86 | 12.54% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 24 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 2,861 | - | - | Feb 29, 2024 |
Kinnate Biopharma's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 196.77K shares, compromising 0.07% of its total assets.
Kinnate Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 60 | -4.76% |
| 31 Dec, 23 | 63 | 8.62% |
| 30 Sep, 23 | 58 | -20.55% |
| 30 Jun, 23 | 73 | -2.67% |
| 31 Mar, 23 | 75 | -7.41% |
| 31 Dec, 22 | 81 | -3.57% |
| 30 Sep, 22 | 84 | 13.51% |
| 30 Jun, 22 | 74 | -3.90% |
| 31 Mar, 22 | 77 | 11.59% |
| 31 Dec, 21 | 69 | -6.76% |
| 30 Sep, 21 | 74 | 21.31% |
| 30 Jun, 21 | 61 | -1.61% |
| 31 Mar, 21 | 62 | 12.73% |
| 31 Dec, 20 | 55 | - |
As of 31 Mar 24, 60 institutions are holding Kinnate Biopharma's shares, representing a decrease of -4.76% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 34,611,276 | -9.75% |
| 31 Dec, 23 | 38,350,735 | -0.59% |
| 30 Sep, 23 | 38,578,905 | -3.69% |
| 30 Jun, 23 | 40,055,445 | -7.41% |
| 31 Mar, 23 | 43,260,098 | 5.97% |
| 31 Dec, 22 | 40,821,709 | -6.33% |
| 30 Sep, 22 | 43,578,104 | 1.10% |
| 30 Jun, 22 | 43,103,873 | 4.37% |
| 31 Mar, 22 | 41,300,856 | -2.49% |
| 31 Dec, 21 | 42,355,340 | 7.65% |
| 30 Sep, 21 | 39,346,935 | 2.75% |
| 30 Jun, 21 | 38,294,075 | 1.21% |
| 31 Mar, 21 | 37,837,670 | 5.08% |
| 31 Dec, 20 | 36,009,634 | - |
Kinnate Biopharma (KNTE) has 34.61M shares outstanding as of 31 Mar 24, down -9.75% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 73.45% | 1.11% |
| 31 Dec, 23 | 81.43% | 1.19% |
| 30 Sep, 23 | 82.69% | 1.06% |
| 30 Jun, 23 | 88.21% | 0.97% |
| 31 Mar, 23 | 95.27% | 1.11% |
| 31 Dec, 22 | 92.64% | 0.95% |
| 30 Sep, 22 | 98.70% | 1.03% |
| 30 Jun, 22 | 97.96% | 1.11% |
| 31 Mar, 22 | 94.12% | 1.00% |
| 31 Dec, 21 | 97.14% | 1.20% |
| 30 Sep, 21 | 90.11% | 1.16% |
| 30 Jun, 21 | 87.96% | 1.16% |
| 31 Mar, 21 | 86.91% | 1.27% |
| 31 Dec, 20 | 82.71% | - |
As of 31 Mar 24, Kinnate Biopharma is held by 73.45% institutional shareholders, representing a 1.11% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 26 | -25.71% |
| 31 Dec, 23 | 35 | 52.17% |
| 30 Sep, 23 | 23 | -43.90% |
| 30 Jun, 23 | 41 | 36.67% |
| 31 Mar, 23 | 30 | -9.09% |
| 31 Dec, 22 | 33 | -19.51% |
| 30 Sep, 22 | 41 | 5.13% |
| 30 Jun, 22 | 39 | 8.33% |
| 31 Mar, 22 | 36 | 9.09% |
| 31 Dec, 21 | 33 | -34.00% |
| 30 Sep, 21 | 50 | 100.00% |
| 30 Jun, 21 | 25 | -34.21% |
| 31 Mar, 21 | 38 | -30.91% |
| 31 Dec, 20 | 55 | - |
26 institutional shareholders have increased their position in KNTE stock as of 31 Mar 24 compared to 35 in the previous quarter (a -25.71% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 19 | 35.71% |
| 31 Dec, 23 | 14 | -33.33% |
| 30 Sep, 23 | 21 | -8.70% |
| 30 Jun, 23 | 23 | 4.55% |
| 31 Mar, 23 | 22 | -15.38% |
| 31 Dec, 22 | 26 | 30.00% |
| 30 Sep, 22 | 20 | 53.85% |
| 30 Jun, 22 | 13 | -35.00% |
| 31 Mar, 22 | 20 | 42.86% |
| 31 Dec, 21 | 14 | 55.56% |
| 30 Sep, 21 | 9 | -55.00% |
| 30 Jun, 21 | 20 | 122.22% |
| 31 Mar, 21 | 9 | - |
| 31 Dec, 20 | - | - |
19 institutional shareholders have reduced their position in KNTE stock as of 31 Mar 24 compared to 14 in the previous quarter (a 35.71% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 60 | -4.76% | 34,611,276 | -9.75% | 73.45% | 1.11% | 26 | -25.71% | 19 | 35.71% |
| 31 Dec, 23 | 63 | 8.62% | 38,350,735 | -0.59% | 81.43% | 1.19% | 35 | 52.17% | 14 | -33.33% |
| 30 Sep, 23 | 58 | -20.55% | 38,578,905 | -3.69% | 82.69% | 1.06% | 23 | -43.90% | 21 | -8.70% |
| 30 Jun, 23 | 73 | -2.67% | 40,055,445 | -7.41% | 88.21% | 0.97% | 41 | 36.67% | 23 | 4.55% |
| 31 Mar, 23 | 75 | -7.41% | 43,260,098 | 5.97% | 95.27% | 1.11% | 30 | -9.09% | 22 | -15.38% |
| 31 Dec, 22 | 81 | -3.57% | 40,821,709 | -6.33% | 92.64% | 0.95% | 33 | -19.51% | 26 | 30.00% |
| 30 Sep, 22 | 84 | 13.51% | 43,578,104 | 1.10% | 98.70% | 1.03% | 41 | 5.13% | 20 | 53.85% |
| 30 Jun, 22 | 74 | -3.90% | 43,103,873 | 4.37% | 97.96% | 1.11% | 39 | 8.33% | 13 | -35.00% |
| 31 Mar, 22 | 77 | 11.59% | 41,300,856 | -2.49% | 94.12% | 1.00% | 36 | 9.09% | 20 | 42.86% |
| 31 Dec, 21 | 69 | -6.76% | 42,355,340 | 7.65% | 97.14% | 1.20% | 33 | -34.00% | 14 | 55.56% |
| 30 Sep, 21 | 74 | 21.31% | 39,346,935 | 2.75% | 90.11% | 1.16% | 50 | 100.00% | 9 | -55.00% |
| 30 Jun, 21 | 61 | -1.61% | 38,294,075 | 1.21% | 87.96% | 1.16% | 25 | -34.21% | 20 | 122.22% |
| 31 Mar, 21 | 62 | 12.73% | 37,837,670 | 5.08% | 86.91% | 1.27% | 38 | -30.91% | 9 | - |
| 31 Dec, 20 | 55 | - | 36,009,634 | - | 82.71% | - | 55 | - | - | - |
Kinnate Biopharma Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Kinnate Biopharma's stock was made by Tananbaum James B. on Apr 05 2024, selling 520,711 shares at $2.59 per share (valued at $1.35M).
Kinnate Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 50 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 32 | 3 | 1066.67% |
| Q1 2023 | 10 | 3 | 333.33% |
| Q4 2022 | - | 3 | - |
| Q3 2022 | 3 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 13 | - | - |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 31 | 29 | 106.90% |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | 1 | - |
0 total buy trades, and 50 total sell trades (buy/sell ratio of 0.00%) were made by Kinnate Biopharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | 26 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 9 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 7 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Kinnate Biopharma's stocks.
Kinnate Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| SLRN | Acelyrin, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| GBIO | Generation Bio Co. |
| SRZN | Surrozen, Inc. |
| KRON | Kronos Bio, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| KROS | Keros Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| WINT | Windtree Therapeutics, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| FIXX | Q32 Bio Inc. |
| PALI | Palisade Bio, Inc. |
KNTE Ownership FAQ
Who Owns Kinnate Biopharma?
Kinnate Biopharma is owned by institutional shareholders (73.45%), insiders (0.16%), and public (26.40%). The largest institutional shareholder of Kinnate Biopharma is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is BlackRock Health Sciences Trust II (0.07% of total shares).
Who are the major institutional shareholders of Kinnate Biopharma?
Kinnate Biopharma's major institutional shareholders are JPMORGAN CHASE & CO, COWEN AND COMPANY, LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and NORTHERN TRUST CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Kinnate Biopharma shareholders are there?
As of Mar 2024, there are 60 institutional shareholders of Kinnate Biopharma.
What percentage of Kinnate Biopharma is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Kinnate Biopharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).
What percentage of Kinnate Biopharma is owned by COWEN AND COMPANY, LLC?
As of Jun 2024, COWEN AND COMPANY, LLC holds 0 shares of Kinnate Biopharma (KNTE), compromising 0% of the company, valued at $0.
What percentage of Kinnate Biopharma is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of Kinnate Biopharma. The company owns 0 of the company's shares outstanding (worth $0).